Stilboestrol and vaginal clear-cell adenocarcinoma syndrome.Br Med J 1978; 1 doi: http://dx.doi.org/10.1136/bmj.1.6127.1588 (Published 17 June 1978) Cite this as: Br Med J 1978;1:1588
- J M Monaghan,
- L A Sirisena
A vaginal clear-cell adenocarcinoma developed in a young woman who had been exposed in utero to maternal stilboestrol treatment. During 1940-71 in the UK some 7500 women were given stilboestrol during pregnancy. Thus more cases are likely to appear and clinicians caring for young women should be alert to this possibility.